05/08/2019 – AB Science provides an update on its masitinib clinical program. Category: 20195 August 2019Tags: 2019Post navigationPreviousPrevious post:Résultats de l’étude sur le masitinib dans le mélanome métastatiqueNextNext post:AB Science to present at two upcoming conferences in September 2019Related PostsPublication of new results in in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS23 December 2019Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood9 December 2019Webcast on masitinib in severe asthma on Monday, December 2, 201926 November 2019Summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis25 November 2019Résumé du webcast avec les principaux leaders d’opinion sur la mastocytose systémique indolente25 November 2019Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities22 November 2019
Publication of new results in in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS23 December 2019
Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood9 December 2019
Résumé du webcast avec les principaux leaders d’opinion sur la mastocytose systémique indolente25 November 2019
Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities22 November 2019
